The current institutional shareholding score of Neurocrine Biosciences Inc is 10.00, ranking 1 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 99.97%, representing a quarter-over-quarter decrease of 0.93%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 2.40% of shares outstanding, with 0.24% decrease in holdings.